Saniona AB (SANION)

Stockholm
3.10
+0.26(+8.96%)
  • Volume:
    509,877
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    3.00 - 3.20
  • Type:Equity
  • Market:Sweden
  • ISIN:SE0005794617
  • S/N:62385677

SANION Overview

Prev. Close
2.85
Day's Range
3-3.2
Revenue
17.09M
Open
3
52 wk Range
1.57-20.3
EPS
-7.39
Volume
509,877
Market Cap
193.4M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,831,507
P/E Ratio
-
Beta
0.8
1-Year Change
-84.51%
Shares Outstanding
62,385,677
Next Earnings Date
24 Aug 2022
What is your sentiment on Saniona AB?
or
Market is currently closed. Voting is open during market hours.

Saniona AB Company Profile

Saniona AB Company Profile

Employees
56
Market
Sweden

Saniona AB (publ), a rare disease biopharmaceutical company, engages in the research, development, and commercialization of treatments for the central nervous system in Denmark. The company’s products include Tesofensine, a monoamine reuptake inhibitor; and Tesomet, a fixed dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical trials for the treatment of prader-willi syndrome and hypothalamic obesity. It also develops SAN711, which is in Phase 1 clinical stage for rare neuropathic disorders; SAN903 that is in preclinical stage for rare inflammatory, fibrotic, and hematological disorders. The company has research and collaboration agreements with Boehringer Ingelheim International GmbH; license agreement with Productos Medix, S.A. de C.V.; research services agreement and a collaboration agreement with Cephagenix ApS. Saniona AB (publ) was founded in 2011 and is headquartered in Glostrup, Denmark.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyBuyBuyStrong Sell
Technical IndicatorsBuyBuyStrong BuyStrong BuyStrong Sell
SummaryBuyStrong BuyStrong BuyStrong BuyStrong Sell